DempoChem Logo
  1. HomeHome
  2. /ProductsProducts
  3. /Bioactive CompoundsBioactive Compounds
  4. /Protein Kinase TargetsProtein Kinase Targets
  5. /ITKITK
  6. /ITK inhibitor 2ITK inhibitor 2
Chemical structure of CAS 1309784-09-5

ITK inhibitor 2

In Stock•Starting at $92 for 1 mg
CAS No.1309784-09-5
MDL No.N/A
MFC25H33N5O2
MW435.60
InChI KeyZZZXGCPVQQOASC-INIZCTEOSA-N
CUSTOM SYNTHESIS

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
1 mgTo Be Confirmed$92In Stock
5 mgTo Be Confirmed$227In Stock
10 mgTo Be Confirmed$365In Stock
25 mgTo Be Confirmed$838In Stock
50 mgTo Be Confirmed$1175In Stock
100 mgTo Be Confirmed$1585In Stock
200 mgTo Be Confirmed$2132In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.1309784-09-5
Product NameITK inhibitor 2
Heavy Atom Count32Rotatable Bond Count4
Atom Stereo Count1Bond Stereo Count0
HBA4HBD2
TPSA77.250 ŲCharge0
Exact Mass435.26343Complexity1138.61
pKa5.875XLogP3.756

Documentation

Your Partner for
Complex Chemistry
logo
  • About Us
  • Perspectives
  • Products
  • Contact
  • Preclinical Development
  • Technologies
  • Custom Synthesis
Ready to start your project?

Provide your target molecule or project specifications to align on a tailored development and scale-up pathway with our scientific team.

START A PROJECT
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
logo

All products are supplied strictly for research and development use only and are not intended for human or veterinary administration, diagnostic use, or therapeutic use. Preclinical and related services are provided solely for research and development purposes and do not constitute clinical diagnosis, treatment, or veterinary care.

©2026 DempoChem. All Rights Reserved.
DHLFedExUPSPostNL
CLIENT PORTAL|TERMS AND CONDITIONS|PRIVACY POLICY|
  • Products
    • CDMO Compounds
    • API & Candidates
  • Services
    CDMO & Manufacturing
    • Custom Synthesis
    • Process Development
    • Lab To Pilot
    • Commercialization
    • Generic APIs
    CRO
    • Preclinical
    • Pharmacology & Efficacy
    • DMPK & Bioanalysis
    • Toxicology & Safety
    • Disease Models
    Technologies
    • High-Potent
    • Chiral Synthesis
    • Cloud Synthesis
    • Fermentation
    • Flow Chemistry
    • Biocatalysis
    Support
    • Regulatory Support
    • Supply Chain Solutions
  • About
  • Perspectives
  • Contact